Performance Evaluation of Different Daily Disposable Silicone Hydrogel Contact Lenses

NCT ID: NCT05805059

Last Updated: 2024-09-26

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-14

Study Completion Date

2023-06-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study is to compare the performance of two daily disposable silicone hydrogel contact lenses.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a prospective, bilateral eye, double masked, randomized, 1-week crossover, daily wear design involving two different daily disposable lens types. Each lens type will be worn for approximately one week.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Contact Lens, Then Test Contact Lens

Participants will wear control contact lenses for one week and then crossover to test contact lenses for one week.

Group Type EXPERIMENTAL

Control Contact Lens (stenfilcon A)

Intervention Type DEVICE

one week wear

Test Contact Lens (senofilcon A)

Intervention Type DEVICE

one week of wear

Test Contact Lens, Then Control Contact Lens

Participants will wear test contact lenses for one week and then crossover to control contact lenses for one week.

Group Type EXPERIMENTAL

Control Contact Lens (stenfilcon A)

Intervention Type DEVICE

one week wear

Test Contact Lens (senofilcon A)

Intervention Type DEVICE

one week of wear

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Control Contact Lens (stenfilcon A)

one week wear

Intervention Type DEVICE

Test Contact Lens (senofilcon A)

one week of wear

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Is between 18 and 35 years of age (inclusively) and has full legal capacity to volunteer;
2. Has read and signed an information consent letter;
3. Self-reports having a full eye examination in the previous two years;
4. Anticipates being able to wear the study lenses for at least 8 hours a day, 7 days a week;
5. Is willing and able to follow instructions and maintain the appointment schedule;
6. Habitually wears soft contact lenses, for the past 3 months minimum;

1. No more than 1/3 of participants should be habitual wearer of MyDay or MyDay Energys
2. No more than 1/3 of participants should be habitual wearer of ACUVUE® OASYS MAX 1-Day or ACUVUE® OASYS 1-Day.
7. Has refractive astigmatism no higher than -0.75DC in each eye;
8. Can be fit and achieve binocular distance vision of at least 20/30 Snellen (Available lens parameters are sphere -1.00 to -6.00D, 0.25D steps).

Exclusion Criteria

1. Is participating in any concurrent clinical or research study;
2. Has any known active ocular disease and/or infection that contraindicates contact lens wear;
3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
4. Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable;
5. Has known sensitivity to the diagnostic sodium fluorescein used in the study;
6. Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
7. Has undergone refractive error surgery or intraocular surgery.
Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre for Ocular Research & Education, Canada

OTHER

Sponsor Role collaborator

CooperVision, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrew Sacco

Role: PRINCIPAL_INVESTIGATOR

Sacco Eye Group, PLLC

Carolyn MacNeil

Role: PRINCIPAL_INVESTIGATOR

Insight Eye Care

Katherine Bickle

Role: PRINCIPAL_INVESTIGATOR

ProCare Vision Center

Roxanne Achong-Coan

Role: PRINCIPAL_INVESTIGATOR

Coan Eye Care

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Coan Eye Care

Ocoee, Florida, United States

Site Status

Sacco Eye Group, PLLC

Vestal, New York, United States

Site Status

ProCare Vision Center

Granville, Ohio, United States

Site Status

Insight Eye Care

Waterloo, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EX-MKTG-145

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.